These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL]. Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569 [TBL] [Abstract][Full Text] [Related]
64. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Mitchell LG; Halton JM; Vegh PA; Barr RD; Venneri T; Pai KM; Andrew ME Am J Pediatr Hematol Oncol; 1994 May; 16(2):120-6. PubMed ID: 8166364 [TBL] [Abstract][Full Text] [Related]
65. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy. Salvador C; Meister B; Crazzolara R; Kropshofer G Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026 [No Abstract] [Full Text] [Related]
66. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia. Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528 [TBL] [Abstract][Full Text] [Related]
67. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870 [TBL] [Abstract][Full Text] [Related]
68. Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia? Maloney KW Pediatr Blood Cancer; 2010 Feb; 54(2):189-90. PubMed ID: 19967774 [No Abstract] [Full Text] [Related]
69. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation. Rodeghiero F; Castaman G; Dini E Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923 [TBL] [Abstract][Full Text] [Related]
70. Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL. Nowak-Göttl U; Werber G; Ziemann D; Ahlke E; Boos J Haematologica; 1996; 81(2):127-31. PubMed ID: 8641640 [TBL] [Abstract][Full Text] [Related]
71. [Automated kinetic assay of plasmatic L-asparaginase activity undergoing therapy for acute lymphoblastic leukemia]. Orsonneau JL; Brassart EA; Lecame M; Thomare P; Delaroche O; Dudouet D Ann Biol Clin (Paris); 2004; 62(5):568-72. PubMed ID: 15355807 [TBL] [Abstract][Full Text] [Related]
72. Risk of thrombosis in pediatric ALL patients--is there a problem! Mathew P Vnitr Lek; 2006 Mar; 52 Suppl 1():132-3. PubMed ID: 16637462 [No Abstract] [Full Text] [Related]
73. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607 [TBL] [Abstract][Full Text] [Related]
74. [Venous thrombosis as a complication of L-asparaginase treatment in a child]. Martínez León MI; Alonso Murciano A Radiologia; 2012; 54(4):372-4. PubMed ID: 21724215 [No Abstract] [Full Text] [Related]
75. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia. Chiewchengchol D; Wananukul S; Noppakun N Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405 [TBL] [Abstract][Full Text] [Related]
76. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase]. Skomra S; Przybylska T Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032 [TBL] [Abstract][Full Text] [Related]
77. Influence of two different regimens of concomitant treatment with asparaginase and dexamethasone on hemostasis in childhood acute lymphoblastic leukemia. Appel IM; van Kessel-Bakvis C; Stigter R; Pieters R Leukemia; 2007 Nov; 21(11):2377-80. PubMed ID: 17554375 [No Abstract] [Full Text] [Related]
78. L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases. Hernández-Espinosa D; Miñano A; Martínez C; Pérez-Ceballos E; Heras I; Fuster JL; Vicente V; Corral J Am J Pathol; 2006 Jul; 169(1):142-53. PubMed ID: 16816368 [TBL] [Abstract][Full Text] [Related]
79. Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study. Kuhle S; Lau A; Bajzar L; Vegh P; Halton J; Cherrick I; Anderson R; Desai S; McCusker P; Wu J; Abshire T; Mahoney D; Mitchell L Br J Haematol; 2006 Sep; 134(5):526-31. PubMed ID: 16856890 [TBL] [Abstract][Full Text] [Related]
80. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia. Zaunschirm A; Muntean W Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]